baber/WOPTO huggingface dataset:
Patent DE-19909825-C5 (DE)
Title: Hülsenförmiges Klemmelement zum abisolierfreien Anschluß elektrischer Leiter
Inventor: WILLINSKI BERND
IPC: H01R4/48
Filed: 1999-03-05
Granted: 2006-01-26
Abstract: Hülsenförmiges Klemmelement
mit einem dem abisolierfreien Anschluß eines elektrischen Leiters
(12) dienenden, in Längsrichtung
des Hülsenkörpers (3)
verlaufenden Klemmschlitz (4), wobei der Hülsenkörper (3) im Querschnitt gesehen
zwei miteinander über
einen Steg (6) einstückig
verbundene, einander gegenüberliegende
Federschenkel (5) aufweist, die in zum Klemmschlitz (4) hin abgewinkelte
Schenkelenden (10) übergehen,
welche den Klemmschlitz (4) begrenzende Schneiden (11) aufweisen,
dadurch gekennzeichnet, daß sich
zumindest einer der beiden Federschenkel (5) in seinem elastisch
verformbaren Bereich zwischen dem Basissteg (6) und der Abwinklung
(9) seines Schenkelendes (10) in Richtung zum Klemmschlitz (4) hin
im Querschnitt verjüngt.
Patent RU-2418891-C9 (RU)
Title: КРИСТАЛЛ SiC ДИАМЕТРОМ 100 мм И СПОСОБ ЕГО ВЫРАЩИВАНИЯ НА ВНЕОСЕВОЙ ЗАТРАВКЕ
Inventor: LEONARD ROBERT TAJLER
IPC: C30B23/00
Filed: 2007-05-30
Granted: 2011-09-10
Abstract: Изобретение относится к полупроводниковым материалам и технологии их получения и может быть использовано в электронике. Полупроводниковый кристалл карбида кремния содержит монокристаллическую затравочную часть 21 и монокристаллическую выращенную часть 22 на указанной затравочной части 21, при этом затравочная 21 и выращенная 22 части образуют по существу правильный цилиндрический монокристалл карбида кремния 20, причем границу раздела между выращенной и затравочной частью определяет затравочная грань 23, которая по существу параллельна основаниям указанного правильного цилиндрического монокристалла 20 и имеет отклонение от оси на угол примерно 0,5°-12° относительно базовой плоскости 26 монокристалла 20, а указанная монокристаллическая выращенная часть воспроизводит политип указанной монокристаллической затравочной части и имеет диаметр, по меньшей мере, примерно 100 мм. Изобретение обеспечивает получение высококачественных (с малым содержанием дефектов) монокристаллов карбида кремния большого диаметра, из которых можно получать отдельные пластины с внеосевыми поверхностями в форме круга. 3 н. и 25 з.п. ф-лы, 7 ил.
Patent RU-2570732-C9 (RU)
Title: Усиленный иммунный ответ у видов птиц
Inventor: EBREKHEM Albert
IPC: A61K39/00
Filed: 2010-05-07
Granted: 2016-09-10
Abstract: Группа изобретений относится к ветеринарии, а именно к способу иммунной активации для повышения вылупляемости оплодотворенного куриного яйца, зараженного Е. coli. Для этого вводят in ovo в яйцо от около 0,05 микрограмма до около 10 микрограммов композиции иммуномодулятора. Композиция иммуномодулятора содержит:  катионное липосомальное средство доставки и молекулу нуклеиновой кислоты бактериального происхождения, не кодирующую иммуноген. Группа изобретений относится к способу снижения смертности цыпленка, вылупившегося из оплодотворенного куриного яйца, зараженного Е. coli, путем введения вышеуказанной композиции. Использование данной группы изобретений позволяет повысить вылупляемость оплодотворенного куриного яйца путем активации усиления иммунного ответа у птиц, зараженных Е. coli. 2 н. и 16 з.п. ф-лы, 8 пр., 8 табл., 42 ил.
Patent RU-2588699-C9 (RU)
Title: Способ калибровки датчика выбранной передачи и система датчиков выбранной передачи
Inventor: KHALLERON Ajan
IPC: G01D18/00
Filed: 2012-08-06
Granted: 2016-12-27
Abstract: Изобретение относится к транспортным средствам с механической трансмиссией. Способ калибровки датчика выбранной передачи для механической трансмиссии с механизмом переключения передач Н-типа, в котором выбираемые передачи расположены в два ряда и имеют несколько параллельных плоскостей движения рычага переключения передач. Механизм переключения передач содержит переключающий элемент, приводимый в движение рычагом переключения передач в угловом и осевом направлениях, в котором контролируют движение переключающего элемента при переключении передач с использованием датчика выбранной передачи. Датчик предоставляет информацию о движении переключающего элемента в направлении включаемой передачи. Преобразуют это движение в скорость в направлении включаемой передачи и используют заранее заданные характеристические изменения скорости для получения калибровочного значения в направлении включаемой передачи. Повышается эффективность определения следующей передачи. 3 н. и 13 з.п. ф-лы, 9 ил.
Patent DK-81688-D0 (DK)
Inventor: BERGSTEIN PAUL LOUIS
IPC: C07C/
Filed: 1988-02-17
Abstract: Radiopharmaceuticals consisting essentially of a lipophilic, charge neutral radionuclide complex of a diaminedithiol ligand having 1-4 ester groups of the formula -A-COOR where A is a straight or branched chain alkylene of 0-10 carbon atoms and R is an alkyl group of 1-10 carbon atoms are useful in radioimaging brain perfusion in primates. Ester-substituted diaminedithiols in sterile, pharmaceutically acceptable form, and kits of the diaminedithiols and sterile, non-pyrogenic reducing agents for reducing preselected radionuclides are also provided. Technetium-99m is a preferred radionuclide. CROSS-REFERENCE TO RELATED APPLICATIONS   This application is a continuation-in-part of copending application Serial No. 016,982, filed February 18, 1987.
Patent DK-82183-D0 (DK)
Inventor: RINNE FRITZ
IPC: F16K27/04
Filed: 1983-02-23
Abstract: 1. An ancillary control device for a closed hydraulic system, in particular for a lifting means for frontmounted equipment on tractors, comprising at least one control spool (10, 11) whose travel movement is restricted by a screwthreaded pin (12, 13) which projects through an opening (16, 17) in the housing of the ancillary control device, characterised in that for the purposes of arresting the adjustable screwthreaded pin (12, 13) when set to a given position in the opening (16, 17) in the housing and for sealing off the opening (16, 17) in the housing with respect to oil issuing therefrom there is exclusively provided an at least region wise coating (18, 19) of microencapsulated permanently plastic synthetic resin on the screwthread (14, 15) of the screwthreaded pin (12, 13).
Patent DK-202189-D0 (DK)
Inventor: BROCKS DIETRICH
IPC: C07K2/00
Filed: 1989-04-26
Abstract: The said peptide can be determined with great accuracy with the aid of a monoclonal antibody which is directed specifically against one epitope of amino-terminal procollagen peptide (type III) which is not present on the fragment Col 1 and of a second monoclonal or polyclonal antibody against an epitope of amino-terminal procollagen peptide (type III).
Patent DK-273287-D0 (DK)
Inventor: SCHAWBEL WILLIAM
IPC: A45D1/02
Filed: 1987-05-27
Abstract: A portable heating appliance (10) has a member (14) to be heated and burner means (152,154) for heating the member (14). A fuel container (18) supplies fuel to the burner means (152,154) and fuel delivery valve means (30) controls the flow of fuel from the container (18) and includes control means (80) for preventing the flow of fuel when in a first position and for permitting the flow of fuel when in a second position. Vaporizer means vaporizes fuel from the container prior to supply to the burner means. A first biasing means (82) biases the control means (80) to the first position and actuator means (16) actuates the fuel delivery valve means in response to user actuation to enable the flow of fuel from the container (18). The actuator means (16) includes plunger (106) means which pushes in the control means (80) from the first position to the second position against the force of the first biasing means to open the fuel delivery valve means (30) so that the latter permits the flow of fuel to said burner means. The appliance also comprises a perforated metal flame arresting screen (186) around the burner means (152,154) for arresting flames during ignition, heat control means (110) being provided for maintaining a substantially constant heat level for the member.
Patent DK-279686-D0 (DK)
Inventor: SAMARUT JACQUES
IPC: C12R1/91
Filed: 1986-06-13
Abstract: PCT No. PCT/FR85/00293 Sec. 371 Date Jun. 4, 1986 Sec. 102(e) Date Jun. 4, 1986 PCT Filed Oct. 15, 1985 PCT Pub. No. WO86/02380 PCT Pub. Date Apr. 24, 1986.The invention relates to a virus for cloning or expression of a foreign gene, characterized in that it consists of all or part of the genome of avian erythroblastosis virus and contains at least one foreign gene situated between the 3 LTR sequences.
Patent DK-328488-D0 (DK)
Inventor: NOGAMI IKUO
IPC: C12P7/58
Filed: 1988-06-16
Abstract: An improved method for producing 2-keto-L-gulonic acid which comprises culturing a microorganism belonging to the genus Pseudogluconobacter which has an ability to oxidize L-sorbose to 2-keto-L-gulonic acid in a culture medium supplemented with a rare earth element in the presence of L-sorbose.
Patent DK-332783-D0 (DK)
Inventor: REMMERS KARL
IPC: B01D53/34
Filed: 1983-07-19
Abstract: 1. Apparatus for the dry cleaning of flue gases which are fouled with gaseous noxious substances, especially sulphur compounds, and which emanate from the burning of fossil fuels especially in boiler plants and ovens, with a section (13) of a regenerative heat exchanger (8) which cools the flue gas and which is arranged in the flue gas duct (18) and with a further section (14) of heat exchanger (8) which is interposed in the combustion air duct (19, 20), the association of the joint solid storage material of the heat exchanger (8) with the two sections (13, 14) thereof varying continuously and periodically, and also with a flue gas duct section which is situated downstream of the cooling section (13) of the heat exchanger (8) and which comprises a bottom grate (15) and contains absorbents, characterized in that in the flue gas duct section which is downstream of the heat exchanger (8) a fluidised bed operated by the flue gas is arranged which has a granular carrier material and has a feed duct (17) for the absorbents, and that a filter (22) is arranged in the flue gas duct (18) after the fluidised bed (16).
Patent DK-468786-D0 (DK)
Inventor: WITTE ERNST-CHRISTIAN
IPC: C07C311/37
Filed: 1986-10-01
Abstract: 1. Sulphonylphenylalkylamines of the formula II   see diagramm : EP0221344,P23,F2   in which R1 represents an alkyl group with 1-6 C-atoms, a cycloalkyl radical with 3-7 C-atoms, an aralkyl, aralkenyl or aryl radical, whereby the aryl moiety can, in each case, be substituted one or more times by halogen, C1 -C6 -alkyl, C1 -C6 -alkoxy, hydroxyl, trifluoromethyl, cyano, nitro, amino, C1 -C6 -alkylamino, C2 -C12 -dialkylamino, C1 -C6 -acylamino, C1 -C16 -acyl or azide, R2 represents a hydrogen atom, an alkyl group with 1-6 C-atoms, an acyl group, an aralkyl or aralkyl or aralkenyl radical, whereby the aryl moiety can, in each case, be substituted one or more times by halogen, C1 -C6 -alkyl, C1 -C6 -alkoxy, hydroxyl, trifluoromethyl, cyano, nitro, amino, C1 -C6 -alkylamino, C2 -C12 - dialkylamino, C1 -C6 -acylamino, C1 -C16 -acyl or azide, B an unbranched or branched alkylene chain with a maximum of 4 C-atoms and A represents an alkyl or alkenyl group with 1-6 C-atoms, a C1 -C6 - formylalkyl radical, a C1 -C6 -hydroxyalkyl group or a radical -D-R3 , in which D signifies a -CO- or -CHOH- group and R3 hydrogen, a C1 -C5 -alkyl, a C1 -C5 - hydroxyalkyl or a C1 -C5 -alkylcarboxylic acid radical, as well as their pharmacologically acceptable salts and their esters, amides and lactones, insofar as these compounds contain a carboxyl group or a hydroxyl and a carboxyl group, with the proviso that for the case that R2 signifies a hydrogen atom or a C1 -C5 -alkyl group and B represents a straight-chained C1 -C3 -alkylene chain A can then only be an alkyl or alkenyl group with 1-6 C-atoms.
Patent DK-580883-D0 (DK)
Inventor: OAKES JOHN
IPC: C11D3/06
Filed: 1983-12-16
Abstract: Built detergent bleach compositions are disclosed comprising a surface-active agent, a peroxide compound bleach (eg. sodium perborate), a manganese compound which delivers manganese (II) ions in aqueous solution (e.g. manganous sulphate or manganous chloride) and a builder mixture comprising a condensed phosphate and an alkalimetal orthophosphate in a weight ratio of from 10:1 to 1:60, preferably from 5:1 to 1:30. The composition is particularly effective for washing fabrics at low temperature, e.g. from 20-60°C, but is also usable at higher temperatures.
Patent NO-874307-D0 (NO)
Inventor: WOLFF REINHARD
IPC: G01B11/16
Filed: 1987-10-15
Abstract: In the process, the optical waveguides are mechanically pretensioned with respect to the component or in themselves to such an extent that for all the deformations to be expected in the component their stress remains within the tensile range. This results in the avoidance of compressions of the fibres of the optical waveguide which lead to undesired attenuation of the light pulses transmitted through the optical waveguide and corrupt the measurement result in connection with stress monitoring. 
<IMAGE>
Patent NO-884136-D0 (NO)
Inventor: WINGEN RAINER
IPC: C09K19/34
Filed: 1988-09-16
Abstract: Phenylpyrimidinyl trans-cyclohexanecarboxylates of the formula 
<IMAGE>
 form, in addition to a relatively broad nematic phase, a smectic C phase if R<1> denotes an alkyl radical having 10 to 16 carbon atoms, in particular 11 to 16 carbon atoms, or an alkyloxy radical having 8 to 14 carbon atoms and R<2> denotes an alkyl radical having 2 to 9 carbon atoms. Accordingly, they are suitable in particular as components of liquid-crystalline mixtures having a smectic C phase, since they induce a relatively broad nematic phase or widen a narrow nematic phase present and enlarge the temperature range of the smectic C phase towards low, but in particular towards high temperatures.
Patent NO-904569-D0 (NO)
Inventor: NAKA TAKEHIKO
IPC: C07D235/06
Filed: 1990-10-23
Abstract: Novel imidazole derivatives of the formula (I): <CHEM> wherein R<1> is an optionally substituted alkyl group, R<2> and R<3> are independently a group capable of forming anion or a group which can be changed thereinto, ring A is benzene ring optionally having, besides the group shown by R<2>, further substituents, and X shows linkage of phenylene group and phenyl group directly or through a spacer whose atomic chain is not more than 2 and a salt thereof, show antagonistic actions to angiotensin II, thus being useful as therapeutics for cardiovascular diseases.
Patent NO-910263-D0 (NO)
Inventor: JARVI ESA TERO
IPC: A61P3/06
Filed: 1991-01-23
Abstract: This invention relates to certain novel di- and tetra-fluoro analogs of squalene and to their methods of use in lowering plasma cholesterol and in inhibiting squalene epoxidase in patients in need thereof.
Patent NO-913175-D0 (NO)
Inventor: HOECHSTETTER CRAIG STEVEN
IPC: C07C215/42
Filed: 1991-08-14
Abstract: The present invention provides novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes, including their corresponding sulfoxides and sulfones, which ring-substituted compounds exhibit agonist activity at the serotonin 1A receptor, of the formula <CHEM>  in which R is C1-C4 alkyl, C3-C4 alkenyl, or cyclopropylmethyl;     R3 is hydrogen; or R and R3 taken together are a divalent group of the formula -CH2CH2CH2-; R1 is hydrogen, C1-C4 alkyl, C3-C4 alkenyl, cyclopropylmethyl, aryl(C1-C4-alkyl), -COR4, -(CH2)nS(C1-C4 alkyl) or -(CH2)nCONR5R6;     n is an integer from 1 to 4;     R4 is hydrogen, C1-C4 alkyl, C1-C4 alkoxy, or phenyl; R5 and R6 are independently hydrogen, C1-C4 alkyl, or C3-C7 cycloalkyl with the proviso that when one of R5 or R6 is cycloalkyl the other is hydrogen;     X is -CH2-, -O-, -S-, <CHEM>     A is <CHEM> R2 is C1-C8 alkyl, substituted C1-C8 alkyl, C2-C4 alkenyl, aryl, substituted aryl, aryl(C1-C4-alkyl), substituted aryl(C1-C4 alkyl), C3-C7 cycloalkyl-substituted methyl, or C3-C7 cycloalkyl; and pharmaceutically acceptable acid addition salts thereof.
Patent NO-920892-D0 (NO)
Inventor: LAMPI KLAUS
IPC: C07F9/38
Filed: 1992-03-06
Abstract: PCT No. PCT/FI90/00197 Sec. 371 Date Apr. 30, 1992 Sec. 102(e) Date Apr. 30, 1992 PCT Filed Aug. 15, 1990 PCT Pub. No. WO91/03480 PCT Pub. Date Mar. 21, 1991.The present invention concerns a novel process for the preparation of methylenebisphosphonic acids of the formula I   <IMAGE> (I)  wherein Q1 and Q2 are independently hydrogen or halogen, by hydrolyzing the corresponding methylenebisphosphonic acid tetraester of the formula   <IMAGE> (II)  wherein R has the meaning of a straight or branched alkyl group containing 1 to 4 carbon atoms, and Q1 and Q2 have the same meaning as above.
Patent NO-921620-D0 (NO)
Inventor: UM GREGORY
IPC: H04N5/66
Filed: 1992-04-27
Abstract: A television display apparatus wherein a white light source emits a beam onto a plurality of dichroic mirrors which split the beam into three beams of the primary colors, then reflects the three primary beams onto three deformable reflective surfaces, which again reflect the beams through slits in a non-reflective surface, thereby modulating the intensity of the beams. The amount of light passing through the slits is horizontally scanned by one surface of a rotating polygonal mirror, then passes through collimating and projection lenses and onto a screen.
Patent NO-922354-D0 (NO)
Inventor: BRECHBUEHLER FRITZ
IPC: E04G21/02
Filed: 1992-06-16
Abstract: The device for limiting a shuttering end face comprises a precast element (1) of a width (W) which corresponds to the thickness of the concrete structure to be erected and of a modular length (L). The element (1) has openings (2) for fitting through reinforcing bars (3), lines (4) or pipes. Since the element is intended to remain in the masonry, it is expediently fabricated from a relatively fine concrete, contained in which is a reinforcing mesh (5) of plastic which also extends over the openings (2) and, in addition, prevents concrete from flowing to the outside when the said concrete is introduced. 
<??>Such a terminating element permits rapid and exact limiting of the shuttering if the masonry is not concreted in one piece or in the case of crane clearances and, moreover, does not require shuttering when concreting the adjoining part. 
<IMAGE>
Patent NO-930380-D0 (NO)
Inventor: BODER GEORGE BERNARD
IPC: C07D307/78
Filed: 1993-02-03
Abstract: This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfon amide, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.
Patent NO-931370-D0 (NO)
Inventor: HORN ELMAR-MANFRED
IPC: C22C38/40
Filed: 1993-04-14
Abstract: The present invention relates to the use of materials for components in contact with hot, concentrated sulphuric acid and from 0 to 10% by weight oleum, and to the preparation of sulphuric acid while employing these materials.
Patent NO-944719-D0 (NO)
Inventor: MEYER PETRUS JOHANNES
IPC: A61K8/00
Filed: 1994-12-07
Abstract: PCT No. PCT/EP93/01405 Sec. 371 Date Feb. 13, 1995 Sec. 102(e) Date Feb. 13, 1995 PCT Filed Jun. 3, 1993 PCT Pub. No. WO93/25213 PCT Pub. Date Dec. 23, 1993Dermatological compositions comprising nitrous oxide and at least one essential fatty acid or lower alkyl ester thereof in a dermatologically acceptable carrier medium is useful in the treatment of a variety of skin, muscle and joint disorders including psoriasis, shingles, fever blisters, chicken pox, ache, chilblains, eczema, chloasmas, alopecia, dermatitis, ringworm and burn wounds. The composition preferably also includes additional ingredients selected from coal tar, collagen, nicotinamide, nicotinic acid, lanolin, vitamin E, methyl salicylate, arnica, and H1-antagonist antihistamines or combinations thereof.
Patent NO-961456-D0 (NO)
Inventor: LANGLOIS MICHEL
IPC: C07C233/32
Filed: 1996-04-12
Abstract: Tricyclic amides of formulae (A1) to (A4), their enantiomers and diastereoisomers, and their salts with bases are new. R1-R6 = H, halo, OH, Ra or ORa; Ra = alkyl opt. substd by one or more halo; alkenyl; alkynyl; cycloalkyl; cycloalkylalkyl; opt. substd. aryl; or opt. substd. arylalkyl; X1 = S, O, C(R5)=C(R6), C(R5)(R5)C(R6)(R6'), C(R5)(R5')C(R6)=, C(R5)(R5') or N(R14); R5', R6' = as for R1-R6; R14 = H, alkyl, opt. substd. aryl, opt. substd. arylalkyl; the dotted bond indicates that it may be single or double; Y = C(R9)(R10); R9, R10 = H, alkyl, or alkoxy; n = 1-3; R7 = H or R7'; R7' = alkyl, opt. substd. aryl or opt. substd. arylalkyl; R8 = COR11 or CSR11; R11 = R12 or NH(R13); R12, R13 = H, alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, opt. substd. aryl or opt. substd. arylalkyl; with the provisos that (a) (I) is not N-(4-methyl- 1H-2,3-dihydro phenalen-2-yl) acetamide, and (b) if X1 = NH or -N(CH3), then R1 = neither H nor halo; alkyl, alkoxy = 1-6C; alkenyl, alkynyl = 2-6C; cycloalkyl = 3-8C; aryl = naphthyl, phenyl or pyridyl; and the opt. substits. on aryl and arylalkyl = halo, alkyl, haloalkyl, alkoxy, or OH.
Patent NO-961625-D0 (NO)
Inventor: BERGE ARVID T
IPC: C08F257/02
Filed: 1996-04-23
Abstract: A procedure for the production of PVC particles with a narrow size distribution in the range 10-50 mum, preferably 10-30 mum, in which, in a first stage, a vinyl monomer or a mixture of monomers is polymerised to form a polymer/oligomer seed particle in the range 1-10 mum. In a second stage, another vinyl monomer or mixture of monomers is swelled into the polymer/oligomer seed particles and polymerisation takes place in such a way that they grow into polymer particles of the desired size. It is preferable to use aromatic vinyl monomers or acrylates as the monomer in the seed particles. The seed particles in the first stage can be produced in a two-stage swelling process or by dispersion polymerisation.
Patent NO-964547-D0 (NO)
Inventor: DUPONT ERIC
IPC: A61K35/32
Filed: 1996-10-25
Abstract: The present invention relates to shark cartilage extracts and to a method of producing the same, these extracts having anti-angiogenic properties (reduction of the area of blood vessels observed in vivo on experimentally induced tumors), tumor regressive activity in vivo as well as demonstrating a direct inhibitory effect on tumor cell lines. This process does not involve any denaturing solvent or product and does not involve the use of any enzymes. It consists of obtaining a blend of whole cartilage in an aqueous solution of neutral pH, preferably pure water, this blend being centrifuged and the pellet and supernatant kept for further processing. The pellet is lyophylized and tested for anti-tumor and anti-angiogenic activities in vivo and in vitro, with or without supernatant. The supernatant has been shown to have anti-angiogenic and tumor regressive activities in vivo. The composition of the supernatant has then been investigated by different ways. Fractionation of this supernatant led to the characterization of some of its active components. The fractions were tested for their direct in vitro activity on cancer cell lines. Therefore, it is assumed that the non-fractionated supernatant has such an in vitro activity. Lyophilization substantially destroys the activity of these liquid fractions while no such abolition is observed in the solid extract.